Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Itama Ranoraya Tbk (IRRA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Itama Ranoraya TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Itama Ranoraya Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Itama Ranoraya Tbk trades at Rp368 (market cap 598.4B, 494.5K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume). The key difference: Itama Ranoraya Tbk and UBC Medical Indonesia Tbk. are close in size by market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 494.5K). Which is the better fit depends on your goals.

IRRALABS
Market Cap
598.4B576.7B
Volume
494.5K3.48M
Lot
4.95K34.82K
Turnover
183.16M522.79M
Average Price
370.4150.13
Value
183.16M522.79M
Indicative Equilibrium Price
368148
Indicative Equilibrium Volume
839350

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IRRA
View details
LABS
View details

About Itama Ranoraya Tbk

PT. Itama Ranoraya Tbk ( theEntity) was established for the first time based on Deed of Establishment of Limited Liability Entity dated November 30, 1989 Number 116, made before Esther Daniar Iskandar, S.H., Notary in Jakarta. PT Global Dinamika Kencana is the majority shareholder of the Entity and also the Ultimate Parent Entity. The entity has started commercial operations at July 22, 2002.

Read more on IRRA

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS